1. Home
  2. KRMD vs LCTX Comparison

KRMD vs LCTX Comparison

Compare KRMD & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRMD
  • LCTX
  • Stock Information
  • Founded
  • KRMD 1980
  • LCTX 1990
  • Country
  • KRMD United States
  • LCTX United States
  • Employees
  • KRMD N/A
  • LCTX N/A
  • Industry
  • KRMD Medical/Dental Instruments
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KRMD Health Care
  • LCTX Health Care
  • Exchange
  • KRMD Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • KRMD 145.4M
  • LCTX 166.3M
  • IPO Year
  • KRMD N/A
  • LCTX N/A
  • Fundamental
  • Price
  • KRMD $3.17
  • LCTX $0.86
  • Analyst Decision
  • KRMD Strong Buy
  • LCTX Strong Buy
  • Analyst Count
  • KRMD 4
  • LCTX 3
  • Target Price
  • KRMD $4.13
  • LCTX $5.67
  • AVG Volume (30 Days)
  • KRMD 47.2K
  • LCTX 446.6K
  • Earning Date
  • KRMD 11-13-2024
  • LCTX 11-14-2024
  • Dividend Yield
  • KRMD N/A
  • LCTX N/A
  • EPS Growth
  • KRMD N/A
  • LCTX N/A
  • EPS
  • KRMD N/A
  • LCTX N/A
  • Revenue
  • KRMD $31,993,796.00
  • LCTX $8,719,000.00
  • Revenue This Year
  • KRMD $15.46
  • LCTX N/A
  • Revenue Next Year
  • KRMD $17.47
  • LCTX $123.52
  • P/E Ratio
  • KRMD N/A
  • LCTX N/A
  • Revenue Growth
  • KRMD 11.57
  • LCTX N/A
  • 52 Week Low
  • KRMD $1.98
  • LCTX $0.77
  • 52 Week High
  • KRMD $3.40
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • KRMD 67.44
  • LCTX 46.44
  • Support Level
  • KRMD $2.60
  • LCTX $0.88
  • Resistance Level
  • KRMD $3.40
  • LCTX $0.97
  • Average True Range (ATR)
  • KRMD 0.23
  • LCTX 0.05
  • MACD
  • KRMD 0.05
  • LCTX 0.00
  • Stochastic Oscillator
  • KRMD 73.86
  • LCTX 37.10

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: